Analyst consensus rating
GoodRx Holdings Analyst Rating: Hold
GDRX is rated Hold by 13 analysts with a $4.03 target. As of 2026-08-26.
Direct answer
GoodRx Holdings's consensus rating is Hold.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.03.
Forecast evidence checked August 26, 2026.
Get free GoodRx Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.48
- Average price target
- $4.03
- High price target
- $5.00
- Low price target
- $2.65
- Low target gap
- -23.7%
- Target upside
- +16%
- High target gap
- +43.9%
- Target range width
- 67.6%
- Consensus rating
- Hold
- Analysts
- 13
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for GoodRx Holdings?
GoodRx Holdings has a verified Hold consensus. The same dataset has an average price target of $4.03.
How far are GoodRx Holdings's low and high targets from the recorded price?
The low target implies -23.7%, while the high target implies +43.9%.
How many analysts are included in GoodRx Holdings's consensus?
The verified consensus includes 13 analysts.
How is GoodRx Holdings's target upside or downside calculated?
The average target of $4.03 is divided by the recorded price of $3.48, then one is subtracted to produce +16%. This does not guarantee a future return.
When was GoodRx Holdings's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.